How to get on a medical advisory board as a physician

Key Signals

• In a Sermo poll of physicians, 65% said they had never been invited to a pharmaceutical advisory board and were unsure how to access those opportunities. Only about 13% were currently serving or had served; about 6% were actively positioning themselves. (Sermo)

• Companies recruit physicians who are already visible in a therapeutic or workflow niche. Roles are rarely posted on Indeed. (Physician Side Gigs; Sermo)

• Typical pharma advisory pay on Sermo’s published ranges: $1,000–$4,000 per meeting, roughly $300–$500/hour. Recurring work with one company often lands around $5,000–$20,000/year. (Sermo)

• “Medical advisory board” in search often means DMV forms. “Physician advisor” often means hospital utilization-management jobs. This article is about industry, device and healthtech seats.

Who this is for (and who it is not for)

This is for clinically active physicians who want paid advisory work with pharma, biotech, device or healthtech companies, and who can clear outside-activity and conflict-of-interest rules with their employer.

It is not for DMV medical advisory board paperwork, hospital utilization-management “physician advisor” jobs, or patient-marketing growth.

You do not need to be a department chair. You do need a narrow problem you can speak about with receipts.

Why this matters now

Plenty of doctors are interested. Far fewer know the invite path. Sermo’s poll and Physician Side Gigs’ communities both show the same gap: how do I get on a board when there is nothing to apply to?

Companies hire the physician they can find and defend. Visibility in one niche beats a vague “open to advisory work” line. Known Doctors exists for that public record: advisory, board, speaking and paid industry work, not patient marketing.

What actually happens when companies fill a board

A pharmaceutical or biotech advisory board is usually a small panel, often about 6 to 12 specialists in one therapeutic area. Early in a program they pressure-test trial design, patient populations and real-world use. Later they weigh in on positioning, guidelines adjacency and workflow fit. (Sermo)

Who identifies you?

• Medical science liaisons (MSLs), medical directors and specialty reps

• Founders and clinical leads at device and healthtech companies

• Expert-matching firms that assemble panels for sponsors

• Peer referrals from physicians already on boards

What they scan: specialty depth, published work or talks, trial exposure, society roles, and a LinkedIn or public page that makes the niche obvious. Sermo’s barrier poll: unsure which platforms or firms to join (29%), difficulty building a KOL-style profile (20%), lack of networking with pharma reps and medical directors (18%). Brand presence on LinkedIn or Sermo was the top brand strategy among respondents at 27%, ahead of conference speaking (19%) and publishing (9%). (Sermo)

Time shape is usually light. In Sermo’s poll, 36% reported 2–5 hours per month; 27% described quarterly meetings of 4–8 hours; 24% said under 2 hours per month, mostly virtual or asynchronous. (Sermo)

The obvious read versus the deeper signal

The obvious read: find “advisory board” listings and apply.

The deeper signal: become findable for one narrow clinical or workflow problem, then make it easy for an MSL, founder or matching firm to put your name forward. Physician Side Gigs is direct about this. Most seats do not land through a public application. Be wary of anyone who charges you to “get on a board,” and be very wary of anyone who asks you to invest in order to join. (Physician Side Gigs)

Role map: what people mean by “advisory”

Pharma / biotech advisory board. Who pays: Manufacturer; Typical ask: 2–4 hour meetings; trial and real-world feedback; How you get in: MSL / medical director invite; matching firms; Watch-outs: Sunshine / Open Payments; employer COI.

Device advisory. Who pays: Device company; Typical ask: Usability, indication, training feedback; How you get in: Reps, medical affairs, specialty meetings; Watch-outs: Same disclosure when payer is a manufacturer.

Healthtech / startup advisory. Who pays: Startup or digital health company; Typical ask: Product, workflow, clinical validation; How you get in: Founder outreach, accelerators, warm intros; Watch-outs: Equity-only offers; vague scope.

Hospital “physician advisor” (UM). Who pays: Health system / payer; Typical ask: Utilization review, peer-to-peer; How you get in: Job postings; Watch-outs: Different job; not this article.

DMV / state medical advisory board. Who pays: State agency; Typical ask: Licence / fitness determinations; How you get in: State process / forms; Watch-outs: Search noise; not industry advisory.

Formal corporate board seat. Who pays: Company; Typical ask: Governance, fiduciary duty; How you get in: Appointability trail; prior advisory helps; Watch-outs: Rare first step for most practicing clinicians.

Expert-network one-off. Who pays: Network client via GLG, Guidepoint, etc.; Typical ask: 30–60 min research call; How you get in: Free registration + complete profile; Watch-outs: On-ramp, not a recurring board.

For pay by engagement type, see What companies actually pay physicians for.

Proof ladder: what makes you easy to invite

1. Clinical credibility: board certification, active practice, depth in a buyer’s problem.

2. Public proof: publications, posters, talks, society roles, or a short LinkedIn About that states the niche without patient-marketing language.

3. Warm intros: MSLs, device reps, founders, and peers who already sit on boards know you are open to the work.

4. First paid session: one meeting, one expert-network call, or a scoped project with a written agreement.

5. Recurring relationship: retainer, repeat board, or multi-meeting engagement with the same company.

You need a niche a non-physician recruiter can defend in one sentence. That is the quiet-expert path in The quiet expert strategy. See also: neurosurgeon advisory and board, radiologist AI advisory.

Compensation context (sourced ranges only)

From Sermo’s pharmaceutical advisory board guide (source):

• Typical meeting pay: $1,000–$4,000, roughly $300–$500/hour

• Recurring single-company relationship: often $5,000–$20,000/year

• Expectation poll for a 2–4 hour consult: 33% expected $1,001–$2,500; 23% expected $500–$1,000; 10% expected $2,501–$4,000

Manufacturer payments to U.S. physicians are generally reportable under Open Payments and searchable on CMS Open Payments. Match every reported payment to a real scope of work.

Startup equity is a different instrument. Market commentary for early-stage advisor grants often cites roughly 0.1%–1% vesting over one to two years, with later-stage meeting advisors often closer to 0.1%–0.25%. Treat that as secondary market commentary, not a guarantee of value. Most startups fail; percentage without capitalization, strike, vesting and exercise terms is not a number you can bank. (Thomson Walsh; forum colour on SDN)

No income guarantees. See also pricing your expertise.

Playbook: templates you can use this month

LinkedIn headline patterns (founders and MSLs, not patients).

• Critical care physician | ICU protocol and workflow advisor

• Interventional cardiologist | device usability and trial feasibility

• Radiologist | imaging AI clinical validation advisor

About section, five lines: specialty and setting; the one problem you advise on; one proof line; that you are open to advisory with manufacturers or healthtech; how to reach you.

Four-sentence outreach (founder or MSL).

Hi [Name], I am a [specialty] at [setting]. I spend most of my clinical time on [narrow problem]. I saw [company / product / trial] and have one practical observation from [setting] that may be useful for [specific decision]. If you are assembling clinical advisors for that work, I am open to a short conversation.

One-page authority bio and on-ramps.

Keep a one-pager (niche, role, three proof assets, disclosure, contact). Expert networks and free matching databases can surface short projects; treat them as listening posts, not the whole strategy. (Physician Side Gigs) Before a conference, tell five people you already know that you are open to advisory work, and ask who owns medical affairs for your niche.

Pitfalls

• Paying for “board seat” access with weak odds of a real company match (PSG)

• Investing cash to “join” an advisory board

• Equity-only startup work with no written scope, vesting or meeting cadence

• Rubber-stamp product endorsements that trade your credentials for marketing cover

• Ignoring employer outside-activity clauses until after you sign

• Chasing every niche instead of one buyer problem

• Confusing hospital UM “physician advisor” postings with industry seats

What to do this week

1. Disambiguate your goal in one sentence: pharma/device board, healthtech advisory, or both.

2. Rewrite five LinkedIn lines (headline + About). No patient-marketing language.

3. List ten target companies that already sell into your specialty or workflow.

4. Send three outreach notes using the four-sentence template.

5. Register on one matching network if appropriate, or go direct if your niche is already warm. Complete the profile with niche keywords.

30- and 90-day observables.

• 30 days: LinkedIn signals advisory interest; at least five warm conversations; one short project call completed or scheduled; outside-activity rules checked.

• 90 days: first paid advisory session or scoped project done; one referral ask after a good call; one public proof asset shipped; any equity offer reviewed in writing.

Bottom line

Advisory invitations follow visibility and trust inside a narrow problem, not a clever application. If you treat your public record as a product, founders and MSLs have something they can defend when they put your name forward.

Timing still depends on specialty demand and employer rules. This week you control the niche sentence, the LinkedIn rewrite, and three outreach notes.

Next step for physicians

If you want a public record that makes advisory invitations easier to earn, start with a Power Hour (60 minutes + 90-day plan) or book a short Meet conversation. Power Hour · Meet

Related reading

• What companies actually pay physicians for

• The quiet expert strategy

• Compliance and visibility

• Pricing your expertise

• Advisory and expert networks

• Insights blog